(Q34820068)

4 August 2017

1 reference

title

Cancer immunotherapy targeting WT1 protein (English)

1 reference

4 August 2017

1 reference

Haruo Sugiyama

1

1 reference

4 August 2017

1 August 2002

1 reference

International Journal of Hematology

4 August 2017

1 reference

4 August 2017

76

1 reference

4 August 2017

2

1 reference

4 August 2017

127-132

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02982574

4 August 2017

0 references

cites work

The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02982574

Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02982574

Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02982574

Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1

21 January 2018

1 reference

12 December 2020

Molecular mechanisms possibly affecting WT1 function in human ovarian tumors

1 reference

12 December 2020

Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

1 reference

12 December 2020

A clinical overview of WT1 gene mutations

1 reference

12 December 2020

Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript

1 reference

12 December 2020

Expression of the Wilms' tumor gene (WT1) in human leukemias

1 reference

12 December 2020

Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination

1 reference

12 December 2020

High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients

1 reference

12 December 2020

Repression of the c-myb gene by WT1 protein in T and B cell lines

1 reference

12 December 2020

Cancer immunotherapy targeting Wilms' tumor gene WT1 product

1 reference

12 December 2020

Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

1 reference

12 December 2020

WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis

1 reference

12 December 2020

Wilms' tumor gene WT1: its oncogenic function and clinical application

1 reference

12 December 2020

Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes

1 reference

12 December 2020

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

1 reference

12 December 2020

YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis

1 reference

12 December 2020

Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.

1 reference

12 December 2020

Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias

1 reference

12 December 2020

Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia

1 reference

12 December 2020

Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma

1 reference

12 December 2020

Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors

1 reference

12 December 2020

WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.

1 reference

12 December 2020

The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor

1 reference

12 December 2020

Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1

1 reference

12 December 2020

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1 reference

12 December 2020

Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma

1 reference

12 December 2020

HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.

1 reference

12 December 2020

WT1 contributes to leukemogenesis: expression patterns in 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia.

1 reference

12 December 2020

Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF).

1 reference

12 December 2020

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

1 reference

12 December 2020

High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome

1 reference

12 December 2020

Wilms' tumor suppressor gene expression in rat and human mesothelioma.

1 reference

12 December 2020

Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.

1 reference

12 December 2020

Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.

1 reference

12 December 2020

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product

1 reference

12 December 2020

Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer

1 reference

12 December 2020

The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells

1 reference

12 December 2020

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

1 reference

12 December 2020

Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus

1 reference

12 December 2020

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

1 reference

12 December 2020

Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens.

1 reference

12 December 2020

Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.

1 reference

12 December 2020

WT1 as a novel target antigen for cancer immunotherapy

1 reference

12 December 2020

Immunity to WT1 in the animal model and in patients with acute myeloid leukemia

1 reference

12 December 2020

Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.

1 reference

12 December 2020

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

1 reference

12 December 2020

Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor

1 reference

12 December 2020

WT1-specific serum antibodies in patients with leukemia

1 reference

12 December 2020

Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression

1 reference

12 December 2020

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1

1 reference

12 December 2020

Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition

1 reference

12 December 2020

Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes

1 reference

12 December 2020

Immunotherapy for leukemia targeting the Wilms' tumor gene

1 reference

12 December 2020

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

1 reference

12 December 2020

Multiple roles for the Wilms' tumor suppressor, WT1.

1 reference

12 December 2020

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.

1 reference

12 December 2020

The role of WT1 in Wilms tumorigenesis

1 reference

12 December 2020

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia

1 reference

12 December 2020

Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1

1 reference

12 December 2020

The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma

1 reference

12 December 2020

HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02982574

1 reference

PubMed ID

12215010

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12215010